Schneider Eugene - Insider Non-Derivative Transactions at IONIS PHARMACEUTICALS INC (IONS) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Feb 2, 2024, Schneider Eugene's relationship to IONIS PHARMACEUTICALS INC (IONS) is Officer (EVP, Chf Clinical Develop Ofcr), and currently has 49,812 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other IONS insiders.

Data Source: SEC.
Schneider Eugene - Insider Non-Derivative Transactions of IONS Common Stock
Schneider Eugene - Insider Non-Derivative Transactions at IONS
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Feb 3, 2024 Sell -- (Common Stock) 2106 49.59 47659
Feb 3, 2024 Sell -- (Common Stock) 2071 49.59 49812
Feb 2, 2024 Acquisition -- (Common Stock) 4033 0 51883
Jan 18, 2024 Sell -- (Common Stock) 5482 50.42 47850
Jan 17, 2024 M -- (Common Stock) 15162 0 53332
Jan 13, 2024 Sell -- (Common Stock) 8000 53.5 38170
Jan 13, 2024 M -- (Common Stock) 8000 32.6 46170
Dec 27, 2023 Sell -- (Common Stock) 25000 51.46 36052
Dec 27, 2023 M -- (Common Stock) 25000 47.34 61052
Feb 7, 2023 Sell -- (Common Stock) 1413 40.67 24946
Feb 4, 2023 Acquisition -- (Common Stock) 4033 0 26359
Jan 19, 2023 Sell -- (Common Stock) 4752 39.57 22326
Jan 18, 2023 M -- (Common Stock) 13046 0 27078